SharePost Content Read More Yahoo Finance #finance Post navigation TD Cowen Remains Bullish on Amicus Therapeutics (FOLD) With a $20 PT RBC Capital Maintained a Buy on BioCryst Pharmaceutical (BCRX), Sets a PT of $13